Hana Biosciences

About:

Hana Biosciences is a biopharmaceutical company developing and commercializing differentiated cancer therapies.

Website: http://www.hanabiosciences.com

Top Investors: Warburg Pincus, Deerfield Capital Management

Description:

Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. The company's lead product candidate, Marqibo(R), potentially treats acute lymphoblastic leukemia and lymphomas.

Total Funding Amount:

$116M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2002-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2010-06-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai